Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels

NCT00104247 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Phenylketonurias

Interventions

DRUG: sapropterin dihydrochloride, 6R-BH4, tetrahydrobiopterin

Sponsor

BioMarin Pharmaceutical